Unknown

Dataset Information

0

Urinary complement factor D is increased in primary malignant hypertension: a single-center, cross-sectional study.


ABSTRACT: Kidney injury is one of the detrimental consequences of primary malignant hypertension (pMHTN). There is a paucity of non-invasive biomarkers to enhance diagnosis and elucidate the underlying mechanisms. This study aims to explore urine protein biomarkers for pMHTN associated renal damage. In the discovery phase, urine samples were collected from 8 pMHTN, 19 disease controls (DCs), and 5 healthy controls (HCs). In-gel digestion combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach was used for identification of proteins associated with pMHTN. In the validation phase, the differentially expressed proteins were validated by ELISA assay in cohort with 10 pMHTN patients, 37 DCs, and 30 HCs. Compared to DCs and HCs, a specific band between 15 and 25 kDa was found in 7 out of 8 patients with pMHTN. Further LC-MS/MS analysis revealed 5 differentially expressed proteins. ELISA validation demonstrated that urinary complement factor D (CFD) was significantly up regulated in pMHTN. By receiver operating characteristic curve analysis, urinary CFD/Cr showed moderate potential in discriminating pMHTN from DCs (the area under curve: 0.822, 95% CI 0.618-0.962). Urinary CFD may be a potential biomarker for pMHTN with its elevation indicative of the activation of the alternative complement pathway in pMHTN.

SUBMITTER: Cheng Y 

PROVIDER: S-EPMC11251191 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Urinary complement factor D is increased in primary malignant hypertension: a single-center, cross-sectional study.

Cheng Yaqi Y   Qin Weiwei W   Lin Liling L   Gao Youhe Y   Li Mingxi M  

Scientific reports 20240715 1


Kidney injury is one of the detrimental consequences of primary malignant hypertension (pMHTN). There is a paucity of non-invasive biomarkers to enhance diagnosis and elucidate the underlying mechanisms. This study aims to explore urine protein biomarkers for pMHTN associated renal damage. In the discovery phase, urine samples were collected from 8 pMHTN, 19 disease controls (DCs), and 5 healthy controls (HCs). In-gel digestion combined with liquid chromatography-tandem mass spectrometry (LC-MS/  ...[more]

Similar Datasets

2024-09-17 | GSE277296 | GEO
| S-EPMC11334361 | biostudies-literature
2017-10-01 | GSE102970 | GEO
| S-EPMC4750802 | biostudies-other
| S-EPMC8989747 | biostudies-literature
| PRJEB50407 | ENA
| S-EPMC10184087 | biostudies-literature
| 2653289 | ecrin-mdr-crc
2014-10-15 | E-MTAB-1977 | biostudies-arrayexpress
| S-EPMC6224670 | biostudies-literature